Matt Cunningham, EVP of Product at Availity, discusses how AI can streamline the prior authorization process, giving clinicians more time for patient care. He discusses current trends and regulatory pressures that make AI suitable for this process, and how it can benefit providers, payers, and patients.
Weight-Loss Drugs Aren’t Really About Weight
While GLP-1 drugs can aid weight loss, their high cost and side effects present challenges. The drugs could be beneficial to people with excess visceral
